Women’s Health

Top Story

Sleep, support essential in treating postpartum depression

September 19, 2017

NEW ORLEANS — Getting adequate amounts of sleep and receiving good social support are major factors in reducing symptoms of postpartum depression and major depressive episodes, according to a presentation at Psych Congress.

For many women, the postpartum period is a very vulnerable window of time, making mood disorders and anxiety common after childbirth, Marlene P. Freeman, MD, of Harvard Medical School, said during her presentation.

In the Journals

Antibiotics reduce post-pregnancy infections in women with pre-pregnancy obesity

September 19, 2017
Among women who were obese before undergoing cesarean delivery, those who received cephalexin and metronidazole for 48 hours after delivery had fewer surgical site…
In the Journals Plus

Post-cesarean cephalexin, metronidazole reduce SSIs in women with obesity

September 19, 2017
Women with obesity who received a 48-hour course of cephalexin and metronidazole after undergoing cesarean delivery experienced reduced rates of surgical site
In the JournalsPerspective

Early miscarriage potentially linked to influenza vaccination

September 14, 2017
Researchers discovered a potential link between miscarriage early in pregnancy and receipt of the influenza A(H1N1)pdm09-containing vaccine in the preceding 28 days…
More Headlines »

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
GI Bookshelf

Question 47: What Is The Best Approach To The Patient With Suspected Sphincter Of Oddi Dysfunction?

From Curbside Consultation of the Pancreas: 49 Clinical Questions
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Meeting News

VIDEO: Adam Brufsky, MD, PhD, discusses results of MONARCH-2, PALOMA-1 trials

June 23, 2017
More »